Multicentre, Randomised, Double-Blind Study to Compare Stalevo [levodopa/carbidopa/entacapone] to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off.

Trial Profile

Multicentre, Randomised, Double-Blind Study to Compare Stalevo [levodopa/carbidopa/entacapone] to Levodopa/Carbidopa in Patients With Parkinson's Disease Experiencing Symptoms of Early Wearing-Off.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Nov 2012

At a glance

  • Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms SEWOP
  • Sponsors Orion Pharma
  • Most Recent Events

    • 17 Jun 2010 Results were reported at the 14th International Congress of Parkinson's Disease and Movement Disorders.
    • 23 Jun 2009 Actual patient number (223) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top